Longwang Wang

640 total citations
25 papers, 461 citations indexed

About

Longwang Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Longwang Wang has authored 25 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Longwang Wang's work include Ferroptosis and cancer prognosis (7 papers), Urinary Bladder and Prostate Research (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Longwang Wang is often cited by papers focused on Ferroptosis and cancer prognosis (7 papers), Urinary Bladder and Prostate Research (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Longwang Wang collaborates with scholars based in China. Longwang Wang's co-authors include Gallina Kazobinka, Xiaomin Han, Qiufeng Pan, Lijie Zhou, Xiaoping Zhang, Bin Li, Teng Hou, Teng Hou, Hao Zhang and Zhaohui Chen and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and ACS Applied Materials & Interfaces.

In The Last Decade

Longwang Wang

23 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Longwang Wang China 12 263 154 114 85 52 25 461
Yuichi Tsujimoto Japan 9 129 0.5× 108 0.7× 45 0.4× 65 0.8× 78 1.5× 38 314
Daohu Wang China 11 181 0.7× 90 0.6× 86 0.8× 70 0.8× 104 2.0× 32 399
Bogdan Petruţ Romania 11 255 1.0× 106 0.7× 230 2.0× 42 0.5× 80 1.5× 41 431
Ju Guo China 13 286 1.1× 161 1.0× 190 1.7× 74 0.9× 67 1.3× 41 458
Lee Spraggon United States 13 397 1.5× 107 0.7× 89 0.8× 37 0.4× 25 0.5× 17 475
Yasuyo Yamamoto Japan 9 143 0.5× 68 0.4× 39 0.3× 56 0.7× 98 1.9× 35 358
Benoît Vallée France 14 236 0.9× 155 1.0× 67 0.6× 70 0.8× 29 0.6× 19 486
Takuto Shimizu Japan 12 168 0.6× 96 0.6× 49 0.4× 94 1.1× 137 2.6× 56 432
Yi Liao China 14 211 0.8× 85 0.6× 98 0.9× 60 0.7× 65 1.3× 19 358

Countries citing papers authored by Longwang Wang

Since Specialization
Citations

This map shows the geographic impact of Longwang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longwang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longwang Wang more than expected).

Fields of papers citing papers by Longwang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longwang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longwang Wang. The network helps show where Longwang Wang may publish in the future.

Co-authorship network of co-authors of Longwang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Longwang Wang. A scholar is included among the top collaborators of Longwang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longwang Wang. Longwang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Qiufeng, et al.. (2025). TFAP2C drives cisplatin resistance in bladder cancer by upregulating YAP and activating β-catenin signaling. Journal of Biological Chemistry. 301(8). 110387–110387. 1 indexed citations
2.
Xiong, Ming, Wencheng Li, Longwang Wang, et al.. (2022). Comprehensive analysis of alternative polyadenylation regulators concerning CD276 and immune infiltration in bladder cancer. BMC Cancer. 22(1). 1026–1026. 6 indexed citations
3.
4.
Pan, Qiufeng, et al.. (2020). The immune infiltration in clear cell Renal Cell Carcinoma and their clinical implications: A study based on TCGA and GEO databases. Journal of Cancer. 11(11). 3207–3215. 53 indexed citations
5.
Liu, Mei, et al.. (2020). A cluster of metabolism-related genes predict prognosis and progression of clear cell renal cell carcinoma. Scientific Reports. 10(1). 12949–12949. 28 indexed citations
6.
Li, Jin, et al.. (2020). Standard versus mini-percutaneous nephrolithotomy for renal stones: a meta-analysis. Scandinavian Journal of Surgery. 110(3). 301–311. 26 indexed citations
7.
Chen, Zhaohui, Lijie Zhou, Xuehan Liu, et al.. (2018). Loss of Fezf2 promotes malignant progression of bladder cancer by regulating the NF-κB signaling pathway. Laboratory Investigation. 98(9). 1225–1236. 5 indexed citations
8.
Hou, Teng, et al.. (2018). Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway. Cellular Physiology and Biochemistry. 47(6). 2250–2260. 24 indexed citations
9.
Wang, Longwang, et al.. (2018). Prognostic Implication of Urothelial Stem Cell Markers Differs According to Primary Tumour Location in Non-Muscle-Invasive Bladder Cancer. Cellular Physiology and Biochemistry. 48(6). 2364–2373. 11 indexed citations
10.
Chen, Zhaohui, Lijie Zhou, Longwang Wang, et al.. (2017). HBO1 promotes cell proliferation in bladder cancer via activation of Wnt/β‐catenin signaling. Molecular Carcinogenesis. 57(1). 12–21. 44 indexed citations
11.
Duan, Ruixue, Zhenyu Zhang, Fuxin Zheng, et al.. (2017). Combining Protein and miRNA Quantification for Bladder Cancer Analysis. ACS Applied Materials & Interfaces. 9(28). 23420–23427. 39 indexed citations
12.
Wang, Longwang, et al.. (2017). Association of increased urine brain derived neurotrophic factor with lower urinary tract symptoms in men with benign prostatic hyperplasia. Journal of Huazhong University of Science and Technology [Medical Sciences]. 37(4). 531–535. 8 indexed citations
13.
Zhang, Weijing, Longwang Wang, Gallina Kazobinka, et al.. (2016). Musashi-2 promotes migration and invasion in bladder cancer via activation of the JAK2/STAT3 pathway. Laboratory Investigation. 96(9). 950–958. 54 indexed citations
14.
Li, Jianlong, et al.. (2016). High expression of constitutive photomorphogenic 1 (COP1) is associated with poor prognosis in bladder cancer. Tumor Biology. 37(7). 8917–8922. 7 indexed citations
15.
Liu, Di, Haipeng Wang, Longwang Wang, et al.. (2014). Urodynamic characteristics of rats with detrusor instability. Computers in Biology and Medicine. 55. 11–15. 1 indexed citations
16.
Wang, Longwang, et al.. (2014). SKIP expression is correlated with clinical prognosis in patients with bladder cancer.. PubMed. 7(4). 1695–701. 4 indexed citations
17.
Wang, Longwang, et al.. (2013). Urinary brain-derived neurotrophic factor: a potential biomarker for objective diagnosis of overactive bladder. International Urology and Nephrology. 46(2). 341–347. 39 indexed citations
18.
Ma, Yan, Bing Li, Longwang Wang, & Xiaomin Han. (2013). The predictive factors of hydronephrosis in patients with spina bifida: reports from China. International Urology and Nephrology. 45(3). 687–693. 5 indexed citations
19.
Yang, Dong, Teng Hou, Xiong Yang, et al.. (2012). Mechanisms of prostate atrophy after LHRH antagonist cetrorelix injection: An experimental study in a rat model of benign prostatic hyperplasia. Journal of Huazhong University of Science and Technology [Medical Sciences]. 32(3). 389–395. 4 indexed citations
20.
Wang, Longwang, Xiaomin Han, Mei Liu, et al.. (2012). Experience in management of Fournier’s gangrene: A report of 24 cases. Journal of Huazhong University of Science and Technology [Medical Sciences]. 32(5). 719–723. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuichi Tsujimoto Breakdown of academic impact, for papers by Daohu Wang Breakdown of academic impact, for papers by Bogdan Petruţ Breakdown of academic impact, for papers by Ju Guo Breakdown of academic impact, for papers by Lee Spraggon Breakdown of academic impact, for papers by Yasuyo Yamamoto Breakdown of academic impact, for papers by Benoît Vallée Breakdown of academic impact, for papers by Takuto Shimizu Breakdown of academic impact, for papers by Yi Liao
Rankless by CCL
2026